JENNIFER NELSON: Open Payments
NPI 1154602332 · DURANT, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 9 payments from 8 companies in 2025. Trend: 2023 $500 · 2024 $505 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Radius Health, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: Ozempic, ENTRESTO, Tymlos, CAPLYTA, Fluad, REXULTI, PROCLAIM, MOUNJARO.
Industry payments across OK — which companies pay providers there.
